We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BPMC market cap is 5.68B. The company's latest EPS is USD -7.9808 and P/E is -11.20.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 56.57M | 71.96M | 96.12M | 138.16M | 128.19M |
| Operating Income | -128.98M | -105.11M | -78.82M | -43.05M | -48.01M |
| Net Income | -133.71M | -110.92M | 89.14M | -50M | -56.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 66.51M | 793.74M | 180.08M | 204.04M | 249.38M |
| Operating Income | -361.33M | 308.71M | -641.98M | -537.52M | -486.28M |
| Net Income | -347.69M | 313.88M | -644.09M | -557.52M | -506.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.11B | 1.05B | 1.04B | 1.2B | 1.2B |
| Total Liabilities | 902.69M | 918.64M | 727.79M | 883.32M | 886.5M |
| Total Equity | 202.61M | 130.61M | 310.69M | 320.24M | 313.15M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 707.69M | 1.72B | 1.25B | 1.35B | 1.05B |
| Total Liabilities | 243.34M | 248.31M | 281.49M | 835.23M | 918.64M |
| Total Equity | 464.36M | 1.47B | 970.74M | 514.68M | 130.61M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -357.92M | -436.85M | -101.51M | -149.59M | -163.22M |
| Investing | 195.27M | 274.04M | 77.13M | -111.16M | -81.21M |
| Financing | 103.7M | 119.23M | 66.96M | 244.98M | 263.35M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -278.02M | 387.04M | -298.65M | -502.28M | -436.85M |
| Investing | -16.47M | -434.25M | -225.86M | -149.54M | 274.04M |
| Financing | 340.64M | 617.76M | 50.72M | 561.81M | 119.23M |
| Market Cap | 5.68B |
| Price to Earnings Ratio | -11.20 |
| Price to Sales Ratio | 22.77 |
| Price to Cash Ratio | 79.66 |
| Price to Book Ratio | 43.48 |
| Dividend Yield | - |
| Shares Outstanding | 63.53M |
| Average Volume (1 week) | 496.19k |
| Average Volume (1 Month) | 597.08k |
| 52 Week Change | -1.65% |
| 52 Week High | 121.90 |
| 52 Week Low | 72.24 |
| Spread (Intraday) | 28.48 (24.77%) |
| Company Name | Blueprint Medicines Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.blueprintmedicines.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
